GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Meheco Group Co Ltd (SHSE:600056) » Definitions » Valuation Rank

China Meheco Group Co (SHSE:600056) Valuation Rank


View and export this data going back to 1997. Start your Free Trial

What is China Meheco Group Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


China Meheco Group Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of China Meheco Group Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


China Meheco Group Co (SHSE:600056) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Guangming Zhongjie, Dongcheng District, Beijing, CHN, 100061
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products and others.
Executives
Qi Jian Xi senior management
Ni Xiao Ling Director